Dentsply Sirona Inc
DENTSPLY SIRONA Inc. develops, manufactures, and markets dental equipment supported by cloud-enabled solutions, dental products, and healthcare consumable products in urology and enterology worldwide. It operates through four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The Connected Technology Solutions segment… Read more
Dentsply Sirona Inc (XRAY) - Net Assets
Latest net assets as of September 2025: $1.48 Billion USD
Based on the latest financial reports, Dentsply Sirona Inc (XRAY) has net assets worth $1.48 Billion USD as of September 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($5.65 Billion) and total liabilities ($4.17 Billion). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $1.48 Billion |
| % of Total Assets | 26.15% |
| Annual Growth Rate | 20.38% |
| 5-Year Change | -60.63% |
| 10-Year Change | -16.94% |
| Growth Volatility | 71.4 |
Dentsply Sirona Inc - Net Assets Trend (1985–2024)
This chart illustrates how Dentsply Sirona Inc's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Dentsply Sirona Inc (1985–2024)
The table below shows the annual net assets of Dentsply Sirona Inc from 1985 to 2024.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | $1.94 Billion | -41.01% |
| 2023-12-31 | $3.29 Billion | -13.59% |
| 2022-12-31 | $3.81 Billion | -23.71% |
| 2021-12-31 | $5.00 Billion | +1.26% |
| 2020-12-31 | $4.93 Billion | -3.14% |
| 2019-12-31 | $5.09 Billion | -0.74% |
| 2018-12-31 | $5.13 Billion | -22.71% |
| 2017-12-31 | $6.64 Billion | -18.27% |
| 2016-12-31 | $8.13 Billion | +247.35% |
| 2015-12-31 | $2.34 Billion | +0.74% |
| 2014-12-31 | $2.32 Billion | -9.92% |
| 2013-12-31 | $2.58 Billion | +14.60% |
| 2012-12-31 | $2.25 Billion | +19.39% |
| 2011-12-31 | $1.88 Billion | -1.35% |
| 2010-12-31 | $1.91 Billion | +0.15% |
| 2009-12-31 | $1.91 Billion | +20.11% |
| 2008-12-31 | $1.59 Billion | +4.70% |
| 2007-12-31 | $1.52 Billion | +19.02% |
| 2006-12-31 | $1.27 Billion | +2.60% |
| 2005-12-31 | $1.24 Billion | -14.04% |
| 2004-12-31 | $1.44 Billion | +28.69% |
| 2003-12-31 | $1.12 Billion | +34.08% |
| 2002-12-31 | $837.19 Million | +37.25% |
| 2001-12-31 | $609.96 Million | +16.20% |
| 2000-12-31 | $524.93 Million | +11.36% |
| 1999-12-31 | $471.40 Million | +13.18% |
| 1998-12-31 | $416.50 Million | -2.66% |
| 1997-12-31 | $427.90 Million | +15.68% |
| 1996-12-31 | $369.90 Million | +15.85% |
| 1995-12-31 | $319.30 Million | +6.68% |
| 1994-12-31 | $299.30 Million | +26.61% |
| 1993-12-31 | $236.40 Million | +245.61% |
| 1992-12-31 | $68.40 Million | +21.06% |
| 1991-12-31 | $56.50 Million | +3.29% |
| 1990-12-31 | $54.70 Million | +140.97% |
| 1989-12-31 | $22.70 Million | +116.19% |
| 1988-12-31 | $10.50 Million | +20.69% |
| 1987-12-31 | $8.70 Million | +262.50% |
| 1986-12-31 | $2.40 Million | +71.43% |
| 1985-12-31 | $1.40 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to Dentsply Sirona Inc's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 83460000000.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | $3.00 Million | 0.15% |
| Other Comprehensive Income | $-730.00 Million | -37.59% |
| Other Components | $3.50 Billion | 180.43% |
| Total Equity | $1.94 Billion | 100.00% |
Dentsply Sirona Inc Competitors by Market Cap
The table below lists competitors of Dentsply Sirona Inc ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Luxi Chemical Group Co Ltd
SHE:000830
|
$2.28 Billion |
|
Kesko Oyj Series A
LSE:0BNS
|
$2.28 Billion |
|
Vietnam National Petroleum Group
VN:PLX
|
$2.28 Billion |
|
TP ICAP Group PLC
PINK:TCAPF
|
$2.28 Billion |
|
Foot Locker Inc
NYSE:FL
|
$2.28 Billion |
|
China National Building Material Company Limited
F:D1Y
|
$2.28 Billion |
|
First Merchants Corporation
NASDAQ:FRME
|
$2.28 Billion |
|
Shenzhen Senior Technology Material Co Ltd
SHE:300568
|
$2.28 Billion |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Dentsply Sirona Inc's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 3,293,000,000 to 1,942,000,000, a change of -1,351,000,000 (-41.0%).
- Net loss of 910,000,000 reduced equity.
- Dividend payments of 126,000,000 reduced retained earnings.
- Share repurchases of 250,000,000 reduced equity.
- Other comprehensive income decreased equity by 94,000,000.
- Other factors increased equity by 29,000,000.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $-910.00 Million | -46.86% |
| Dividends Paid | $126.00 Million | -6.49% |
| Share Repurchases | $250.00 Million | -12.87% |
| Other Comprehensive Income | $-94.00 Million | -4.84% |
| Other Changes | $29.00 Million | +1.49% |
| Total Change | $- | -41.03% |
Book Value vs Market Value Analysis
This analysis compares Dentsply Sirona Inc's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 1.28x
- The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
- The price-to-book ratio has decreased from 261.73x to 1.28x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 1985-12-31 | $0.05 | $12.22 | x |
| 1986-12-31 | $0.07 | $12.22 | x |
| 1987-12-31 | $0.29 | $12.22 | x |
| 1988-12-31 | $0.31 | $12.22 | x |
| 1989-12-31 | $0.66 | $12.22 | x |
| 1990-12-31 | $1.26 | $12.22 | x |
| 1991-12-31 | $1.07 | $12.22 | x |
| 1992-12-31 | $1.29 | $12.22 | x |
| 1993-12-31 | $1.51 | $12.22 | x |
| 1994-12-31 | $1.80 | $12.22 | x |
| 1995-12-31 | $1.95 | $12.22 | x |
| 1996-12-31 | $2.26 | $12.22 | x |
| 1997-12-31 | $2.61 | $12.22 | x |
| 1998-12-31 | $2.57 | $12.22 | x |
| 1999-12-31 | $2.95 | $12.22 | x |
| 2000-12-31 | $3.31 | $12.22 | x |
| 2001-12-31 | $3.86 | $12.22 | x |
| 2002-12-31 | $5.22 | $12.22 | x |
| 2003-12-31 | $6.96 | $12.22 | x |
| 2004-12-31 | $8.80 | $12.22 | x |
| 2005-12-31 | $7.66 | $12.22 | x |
| 2006-12-31 | $8.05 | $12.22 | x |
| 2007-12-31 | $9.80 | $12.22 | x |
| 2008-12-31 | $10.47 | $12.22 | x |
| 2009-12-31 | $12.21 | $12.22 | x |
| 2010-12-31 | $12.60 | $12.22 | x |
| 2011-12-31 | $12.87 | $12.22 | x |
| 2012-12-31 | $15.34 | $12.22 | x |
| 2013-12-31 | $17.48 | $12.22 | x |
| 2014-12-31 | $16.10 | $12.22 | x |
| 2015-12-31 | $16.41 | $12.22 | x |
| 2016-12-31 | $36.62 | $12.22 | x |
| 2017-12-31 | $28.90 | $12.22 | x |
| 2018-12-31 | $22.83 | $12.22 | x |
| 2019-12-31 | $22.70 | $12.22 | x |
| 2020-12-31 | $22.50 | $12.22 | x |
| 2021-12-31 | $22.69 | $12.22 | x |
| 2022-12-31 | $17.69 | $12.22 | x |
| 2023-12-31 | $15.53 | $12.22 | x |
| 2024-12-31 | $9.56 | $12.22 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Dentsply Sirona Inc utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -46.86%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -23.99%
- • Asset Turnover: 0.66x
- • Equity Multiplier: 2.96x
- Recent ROE (-46.86%) is below the historical average (8.76%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 1985 | 7.14% | 0.97% | 1.37x | 5.36x | $-40.00K |
| 1986 | 33.33% | 6.30% | 1.46x | 3.63x | $560.00K |
| 1987 | 14.94% | 8.02% | 1.29x | 1.45x | $430.00K |
| 1988 | 16.19% | 9.14% | 1.35x | 1.31x | $650.00K |
| 1989 | 10.57% | 8.16% | 0.37x | 3.48x | $130.00K |
| 1990 | 5.30% | 5.32% | 0.67x | 1.48x | $-2.57 Million |
| 1991 | 9.38% | 6.26% | 0.91x | 1.64x | $-350.00K |
| 1992 | 7.75% | 6.26% | 0.68x | 1.81x | $-1.54 Million |
| 1993 | 5.96% | 2.55% | 1.10x | 2.13x | $-9.54 Million |
| 1994 | 20.72% | 11.81% | 1.11x | 1.59x | $32.07 Million |
| 1995 | 17.09% | 9.44% | 0.96x | 1.89x | $22.41 Million |
| 1996 | 18.38% | 10.23% | 0.98x | 1.83x | $30.64 Million |
| 1997 | 17.60% | 10.35% | 0.93x | 1.83x | $32.21 Million |
| 1998 | 8.41% | 4.38% | 0.89x | 2.16x | $-6.58 Million |
| 1999 | 19.17% | 10.82% | 0.97x | 1.83x | $43.01 Million |
| 2000 | 19.41% | 11.35% | 1.03x | 1.67x | $48.98 Million |
| 2001 | 19.93% | 10.76% | 0.63x | 2.95x | $60.54 Million |
| 2002 | 17.70% | 9.77% | 0.73x | 2.50x | $64.36 Million |
| 2003 | 15.52% | 11.09% | 0.64x | 2.18x | $61.98 Million |
| 2004 | 17.53% | 14.94% | 0.61x | 1.94x | $108.77 Million |
| 2005 | 3.66% | 2.65% | 0.71x | 1.94x | $-78.75 Million |
| 2006 | 17.56% | 12.36% | 0.83x | 1.71x | $96.33 Million |
| 2007 | 17.13% | 12.92% | 0.75x | 1.76x | $108.04 Million |
| 2008 | 17.88% | 12.94% | 0.78x | 1.78x | $125.10 Million |
| 2009 | 14.97% | 12.70% | 0.70x | 1.69x | $91.05 Million |
| 2010 | 14.45% | 11.96% | 0.68x | 1.77x | $81.77 Million |
| 2011 | 13.23% | 9.64% | 0.53x | 2.57x | $59.71 Million |
| 2012 | 14.23% | 10.73% | 0.59x | 2.25x | $93.34 Million |
| 2013 | 12.35% | 10.61% | 0.58x | 2.00x | $59.69 Million |
| 2014 | 13.91% | 11.05% | 0.63x | 2.00x | $90.73 Million |
| 2015 | 10.74% | 9.39% | 0.61x | 1.88x | $17.40 Million |
| 2016 | 5.30% | 11.48% | 0.32x | 1.44x | $-381.53 Million |
| 2017 | -23.38% | -38.81% | 0.38x | 1.57x | $-2.21 Billion |
| 2018 | -19.74% | -25.36% | 0.46x | 1.70x | $-1.52 Billion |
| 2019 | 5.03% | 6.36% | 0.47x | 1.69x | $-253.30 Million |
| 2020 | -1.48% | -2.19% | 0.36x | 1.90x | $-566.20 Million |
| 2021 | 8.23% | 9.71% | 0.46x | 1.85x | $-88.60 Million |
| 2022 | -24.92% | -24.22% | 0.51x | 2.00x | $-1.33 Billion |
| 2023 | -4.01% | -3.33% | 0.54x | 2.24x | $-461.30 Million |
| 2024 | -46.86% | -23.99% | 0.66x | 2.96x | $-1.10 Billion |
Industry Comparison
This section compares Dentsply Sirona Inc's net assets metrics with peer companies in the Medical Instruments & Supplies industry.
Industry Context
- Industry: Medical Instruments & Supplies
- Average net assets among peers: $2,683,526,542
- Average return on equity (ROE) among peers: -32.48%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Dentsply Sirona Inc (XRAY) | $1.48 Billion | 7.14% | 2.82x | $2.28 Billion |
| ANGELALIGN TECHNOLOGY INC (AGLFF) | $480.24 Million | 2.52% | 0.41x | $405.57 Million |
| Akoya Biosciences Inc (AKYA) | $-30.16 Million | 0.00% | 0.00x | $16.24 Million |
| Alcon AG (ALC) | $19.68 Billion | 1.70% | 0.48x | $37.82 Billion |
| Align Technology Inc (ALGN) | $3.85 Billion | 10.94% | 0.61x | $11.75 Billion |
| AngioDynamics Inc (ANGO) | $355.71 Million | 3.06% | 0.15x | $354.40 Million |
| Ansell Limited (ANSLF) | $386.33 Million | -0.45% | 0.87x | $2.58 Billion |
| AptarGroup Inc (ATR) | $2.07 Billion | 11.57% | 1.03x | $8.27 Billion |
| AtriCure Inc (ATRC) | $72.60 Million | -15.79% | 0.54x | $1.42 Billion |
| Avinger Inc (AVGR) | $-35.69 Million | 0.00% | 0.00x | $1.26 Million |
| Anteris Technologies Global Corp. Common Stock (AVR) | $9.03 Million | -338.35% | 0.77x | $156.14 Million |